Our results strongly suggest that PLCε1 can be a potentially promising biomarker for distinguishing gastric cancer from atrophic gastritis and might be a potential biomarker for diagnosing early-stage gastric cancer. Here, PLCE1 is linked to chronic atrophic gastritis.